Quick Asked: Zentalis Pharmaceuticals Contact Us?
Last update: 28 Apr, 2024 
399 Views
Listing Results Zentalis Pharmaceuticals Contact Us? Question Answers
Zentalis Pharmaceuticals Information Zentalis
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities
Contact Zentalis Pharmaceuticals
212-433-3791 About Us. Contact. Contact Get In Touch. PHONE. 1-212-433-3791. EMAIL ADDRESS. info@ zentalis.com. Locations. Science Center. ...
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals Announces Fast Track Designation Granted by the U.S. FDA to ZN-c3 for the Treatment of Uterine Serous Carcinoma. November 10, 2021. Zentalis Pharmaceuticals Reports Third Quarter 2021 Financial Results and ...
Zentalis Pharmaceuticals San Diego CA, 92121 – Manta.com
(858) 263-4333 Zentalis Pharmaceuticals, LLC 10835 Road To The Cure San Diego, CA 92121 (858) 263-4333 Visit Website Get Directions Similar Businesses Detailed Information Location TypeSingle Location Year Established2017 Annual Revenue Estimate417255 SIC Code show NAICS Code show Employees4 Contactsshow There are no reviews yet. Be the first to write one!
Zentalis Pharmaceuticals Company Profile Office
Zentalis Pharmaceuticals. Frequently Asked Questions. When was Zentalis Pharmaceuticals founded?. Zentalis Pharmaceuticals was founded in 2014.. Who are Zentalis Pharmaceuticals key executives?. Zentalis Pharmaceuticals's key executives are Anthony Sun, Kevin Bunker and Robert Winkler.. How many employees does Zentalis ...
Zentalis Pharmaceuticals IPOScoop
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums), is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not ...
Gain Therapeutics and Zentalis Pharma collaborate on
On April 20th, 2021, Gain Therapeutics announced a multi-target drug discovery and development deal with Zentalis Pharmaceuticals to identify and address novel oncology targets. Gain will be using its proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) computational platform technology to identify new and previously difficult-to
Zentalis Pharmaceuticals Crunchbase Company Profile
212-433-3791 Phone Number 212-433-3791 Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental biological pathways in cancer. Lists Featuring This Company Viking Global Investors Portfolio Companies
Zentalis Pharmaceuticals LinkedIn
Zentalis Pharmaceuticals Biotechnology New York, NY 9,756 followers Developing small molecule therapeutics targeting fundamental biological pathways of cancers
ZNTL Zentalis Pharmaceuticals Inc. Profile MarketWatch
212 433-3791 Zentalis Pharmaceuticals Inc. 530 7th Avenue Suite 2201 New York, New York 10018 Phone 1 212 433-3791 Industry Biotechnology Sector Health Care/Life Sciences Fiscal Year-end 12/2021 Revenue N/A Net
Zentalis Overview, News & Competitors ZoomInfo.com
(212) 433-3791 Where are Zentalis’s headquarters? Zentalis’s headquarters are in 530 Seventh Ave., Ste. 2201, New York City, New York, 10018, United States What is Zentalis’s phone number? Zentalis’s phone number is (212) 433-3791 What is Zentalis’s official website? Zentalis’s official website is //www.zentalis.com What is Zentalis’s Revenue?